Acción A204840 GL PHARM TECH CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas GL Pharm Tech Corp.

Acciones

A204840

KR7204840003

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 10/05/2024 		Varia. Cinco días. Varia. 1 de enero.
1.225 KRW -0,08 % Gráfico intradía de GL Pharm Tech Corp. -2,78 % +7,83 %
03/05 Un comprador no revelado adquirió una participación del 3,23% en GL Pharm Tech Corp. (KOSDAQ:A204840) a Ideal Private Equity Fund por 3.970 millones de KRW. CI
06/03 W Science Co., Ltd. completó la adquisición de una participación del 14,75% en GL Pharm Tech Corp. (KOSDAQ:A204840) a Ideal Private Equity Fund CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
An undisclosed buyer acquired 3.23% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund for KRW 3.97 billion.
W Science Co., Ltd. completed the acquisition of 14.75% stake in GL Pharm Tech Corp. from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 9.199999458 billion in funding from W Science Co., Ltd.
GL Pharm Tech to Raise 9.2 Billion Won via Share Issuance; Shares Decline 7%
GL Pharm Tech Corp. announced that it expects to receive KRW 9.199999458 billion in funding from W Science Co., Ltd.
W Science Co., Ltd. agreed to acquire a 14.7% stake in GL Pharm Tech Corp.
GL Pharm Tech Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. Auditor Raises 'Going Concern' Doubt
GL Pharm Tech Corp. announced that it expects to receive KRW 8.999999634 billion in funding from Ideal Private Equity Fund
GL Pharm Tech Corp. announced that it has received KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000232 billion in funding from Kyperion Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 1.000000534 billion in funding from Kuhnil Pharmaceutical Co., Ltd.
GL Pharm Tech Corp. announced that it has received KRW 3.1 billion in funding from Unione Communications Co., Ltd.
GL Pharm Tech Corp. announced that it expects to receive KRW 3.1 billion in funding from Unione Communications Co., Ltd. and other investors
Crown Pharm Co., Ltd. announced that it has received KRW 1.00001 billion in funding from GL Pharm Tech Corp.
Crown Pharm Co., Ltd. announced that it has received KRW 3.00003 billion in funding from GL Pharm Tech Corp.
GL Pharm Tech Corp. announced that it has received KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC. and other investors
GL Pharm Tech Corp. announced that it expects to receive KRW 7 billion in funding from Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, E&INVESTMENT INC., and other investors
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A204840
  4. Noticias GL Pharm Tech Corp.
  5. Otros idiomas